BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/29/2021 8:35:47 AM | Browse: 598 | Download: 1404
 |
Received |
|
2021-01-18 11:55 |
|
Peer-Review Started |
|
2021-01-18 11:57 |
|
First Decision by Editorial Office Director |
|
2021-02-09 21:02 |
|
Return for Revision |
|
2021-02-10 12:42 |
|
Revised |
|
2021-02-11 07:51 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-03-16 12:09 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-03-17 05:54 |
|
Articles in Press |
|
2021-03-17 05:54 |
|
Edit the Manuscript by Language Editor |
|
2021-03-29 13:03 |
|
Typeset the Manuscript |
|
2021-04-08 04:16 |
|
Publish the Manuscript Online |
|
2021-04-29 08:35 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Prediction models for the development of hepatocellular carcinoma in chronic hepatitis B patients
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Jiang Guo and Xue-Song Gao |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Science and Technology Major Project of China |
2018ZX10715-005-003-002 |
| Health Development and Scientific Research in the Capital |
2018-1-2181 |
|
| Corresponding Author |
Xue-Song Gao, MD, PhD, Chief Physician, Department of General Medicine, Beijing Ditan Hospital, Capital Medical University, No. 8 Jingshundong Street, Chaoyang District, Beijing 100015, China. gaoxuesong@ccmu.edu.cn |
| Key Words |
Antiviral agents; Hepatitis B virus; Hepatocellular carcinoma; Liver cirrhosis; Risk factors; Proportional hazards models |
| Core Tip |
Risk scores are useful in estimating hepatocellular carcinoma (HCC) risk in chronic hepatitis B (CHB) patients. While antiviral therapy does not eliminate the risk of hepatitis B virus (HBV)-related HCC, it modifies the natural disease course to reduce the HCC risk. CU-HCC (Chinese University-HCC), GAG-HCC (guide with age, gender, HBV DNA, core promoter mutations and cirrhosis) and REACH-B (risk estimation for HCC in CHB) scores derived from Asian CHB patients were also accurate in treated patients. The PAGE-B (platelet, age, and gender-hepatitis B) score has persistently high predictability for treated Caucasian and Asian patients with different HCC risk profiles. |
| Publish Date |
2021-04-29 08:35 |
| Citation |
Guo J, Gao XS. Prediction models for the development of hepatocellular carcinoma in chronic hepatitis B patients. World J Clin Cases 2021; 9(14): 3238-3251 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i14/3238.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i14.3238 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
